Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:02795157n
Noun Named Entity
Categories: Companies listed on NYSE MKT, Companies listed on TASE, Pharmaceutical companies established in 1993, Biotechnology companies of Israel, Pharmaceutical companies of Israel
EN
Protalix BioTherapeutics  Protalix  Protalix BioTherapeutics, Inc  Protalix BioTherapeutics, Inc.  Protalix BioTherapeutics Inc.
EN
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
Definitions
Relations
Sources
EN
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
IS A
commercial enterprise
public company
COUNTRY
Israel
FOUNDED BY
Joseph Chaaltiel
HEADQUARTERS LOCATION
Karmiel
INDUSTRY
biotechnology
PRODUCT OR MATERIAL PRODUCED
Taliglucerase alfa
STOCK EXCHANGE
American Stock Exchange
Tel Aviv Stock Exchange
Wikipedia
EN
Protalix BioTherapeutics
Wikidata
EN
Protalix BioTherapeutics
Wikipedia Redirections
EN
Protalix, Protalix BioTherapeutics, Inc, Protalix BioTherapeutics, Inc.
Wikidata Alias
EN
Protalix BioTherapeutics Inc.

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License